Table 4 Two patients with S. aureus isolates with a dalbavancin MIC of 0.25 μg/ml
Characteristic | Patient 1 | Patient 2 |
|---|---|---|
Treatment Group | Vancomycin/linezolid | Dalbavancin |
Age (years) | 51 | 34 |
Type of infection | Traumatic Wound Infection | Cellulitis |
Wound culture | MSSA | MRSA |
Vancomycin MIC | 1 | 0.5 |
PVL toxin | Negative | Positive |
mecA gene | Negative | Positive |
Clinical response at 48–72 hours | Responder | Responder |
Clinical outcome at Day 14 | Success | Success |